TOKYO,March 11,2025-- Nellify,Japan\'s premier luxury mattress brand owned by Morght Co.,Ltd.,is now available in the United States,offering an unparalleled sleep experience crafted with Japanese prec
HEFEI,China,March 11,2025-- BloombergNEF (BNEF) has published the results of its 2024 PV Module and Inverter Bankability Survey,naming Sungrow the only inverter supplier to receive a global No.1ratin
BEIJING,March 11,2025-- Cheche Group Inc.(NASDAQ: CCG) ("Cheche" or the "Company"),China\'s leading auto insurance technology platform,today announced that it has received a notifi
SINGAPORE,March 11,2025--Digital travel platform Agoda has observed a 358% increase in accommodation searches for Singapore following the announcement of exclusive Lady Gaga concerts scheduled for Ma
DAVIS,Calif.,March 11,2025-- openRxiv has officially launched as an independent nonprofit to oversee bioRxiv and medRxiv,the world\'s leading preprint servers for life and health sciences. openRxiv en
NUREMBERG,Germany,March 11,2025-- Fibocom (Stock code:300638),a global leading provider of AIoT solutions and wireless communication modules,showcases its latest advancements in consumer electronics,
TAIPEI,March 12,2025-- The Asian Auto & Motorcycle Parts Online Exhibition 2025 (AAMPA 2025) is set to launch,offering international buyers a premier opportunity to connect with Asia\'s leading su
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).